Global Sever’s Disease Treatment Market, By Type (Acute, Chronic), Treatment (NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), Immobilization, Physical Therapy, Ice therapy, Others), Diagnosis (X-ray, Squeeze Test, Magnetic Resonance Imaging (MRI), Others), Symptoms (Pain in the back or bottom of the heel, Difficulty running, jumping or participating in usual activities or sports, Walking on toes, Pain when the sides of the heel are squeezed, Limping, Tiredness, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Injectable, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Sever’s Disease Treatment Market
Sever’s disease treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5% in the above mentioned forecast period.
Sever's disease is a frequent ailment in youngsters that causes heel discomfort. High-impact sports and activities that put pressure on a growth plate in the heel exacerbate the pain. Children and teenagers have growth plates, which are cartilage pieces that connect their bones. Growth plates harden into bone as we become older. Sever's disease is an injury rather than an illness. It is outgrown by children over time. In the meantime, rest, pain medication, and correct footwear are generally enough to alleviate symptoms. Symptoms of this condition include pain in the back or bottom of the heel, difficulty running, jumping or participating in usual activities or sports, walking on toes, pain when the sides of the heel are squeezed, limping and tiredness. Calcaneal apophysitis is another name for this condition.
The rise in the prevalence of Sever's disease and growing incidences of obesity are the major factors influencing the market growth rate. Furthermore, growing government funding and rising initiatives by public and private organisations to spread awareness about the disease and its available treatment are the factors that will expand the Sever’s disease treatment market. Other factors including rising healthcare expenditure and increase in the demand for novel therapies will positively impact the market growth rate.
Rise in the research and development activities and emerging markets will provide beneficial opportunities for the Sever’s disease treatment market in the forecast period of 2021-2028.
However, high cost of the treatment and complications associated with the disease are the factors that will hinder the market growth. Lack of awareness about preventive measures will further challenge the Sever’s disease treatment market in the forecast period mentioned above.
This Sever’s disease treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Sever’s disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Sever’s Disease Treatment Market Scope and Market Size
The Sever’s disease treatment market is segmented on the basis of type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the Sever’s disease treatment market is segmented into acute and chronic.
- On the basis of treatment, the Sever’s disease treatment market is segmented into NSAIDs (non-steroidal anti-inflammatory drugs), immobilization, physical therapy, ice therapy, and others.
- On the basis of diagnosis, the Sever’s disease treatment market is segmented into x-ray, squeeze test, magnetic resonance imaging (MRI) and others.
- On the basis of symptoms, the Sever’s disease treatment market is segmented into pain in the back or bottom of the heel, difficulty running, jumping or participating in usual activities or sports, walking on toes, pain when the sides of the heel are squeezed, limping, tiredness and others.
- On the basis of dosage, the Sever’s disease treatment market is segmented into tablet, injection and others.
- On the basis of route of administration, the Sever’s disease treatment market is segmented into oral, injectable and others.
- On the basis of end-users, the Sever’s disease treatment market is segmented into clinic, hospital and others.
- The Sever’s disease treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Sever’s Disease Treatment Market Country Level Analysis
Sever’s disease treatment market is analyzed and market size information is provided by the country, type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Sever’s disease treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the Sever’s disease treatment market due to presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Sever’s disease treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Sever’s Disease Treatment Market Share Analysis
Sever’s disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Sever’s disease treatment market research.
The major players covered in the Sever’s disease treatment market report are Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Boehringer Ingelheim International GmbH., AstraZeneca, Johnson & Johnson Private Limited, Horizon Therapeutics plc., Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Reckitt Benckiser Group PLC, Cipla Inc., Sumitomo Dainippon Pharma Co., Ltd., LEO Pharma A/S, F. Hoffmann-La Roche Ltd., AbbVie Inc., Zyla Life Sciences, Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lonza, Dr. Reddy’s Laboratories Ltd., Iroko Pharmaceuticals Inc., Assertio Holdings, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-